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The study examined changes in the use of antiepileptic drugs (AEDs) in a large hospital for people with a learning disability over
a 2 year period, the use of investigations, and the presence of medication side-effects. The surveys were carried out in 1993 and
1995/6. In 1993, 27% of patients were being treated for epilepsy and in 1995/6, 30.1%. Ninety percent and 82.4% of patients,
respectively, were receiving one or two AEDs. In the second survey there were fewer prescriptions for phenobarbitone (5.8%
vs. 12.5%) and an increase in the use of lamotrigine (21.6% vs. 5%), gabapentin (5.8% vs. 0) and vigabatrin (3.9% vs. 2.5% in
1993). Side-effects were recorded in 6 (11.8%) patients. Seven (21.2%) patients receiving carbamazepine were found to have
hyponatraemia. Of the 54 electroencephalograms (EEGs) requested, 41 (76%) were reported as abnormal. Six CT brain scans
had been conducted, of which five were abnormal. People receiving antipsychotic drugs had fewer seizures than average.
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Compared to the general population, epilepsy is more
prevalent among the learning disabled. It may also be
more difficult to manage. Assessment and manage-
ment strategies are similar to those used for the non-
disabled population, but they may have to be modified
to take account of communication problems, the pres-
ence of additional disabilities or disorders and the use
of other medications. Recognized practices in epilepsy
management include the use of EEGs to confirm the
diagnosis or to distinguish genuine seizures from non-
epileptic seizures, tics or motor stereotypies. As in
the general population, video recording of suspected
seizures can supplement this. Computed tomography
can also be used to assist aetiological diagnosis and
to document changes1. For confirmed epilepsy, con-
trol with monotherapy is the ideal, although many new
antiepileptic drugs (AEDs) are initially licensed only
for ‘add on’ therapy. An appropriate AED is selected
depending on the type of seizures or syndrome identi-
fied. Seizure frequency can be monitored using diaries
(or charts in hospital patients). Regular observation for1059–1311/99/030175 + 06 $12.00/0any obvious AED side-effects is important. Monitoring
of AED serum levels can also be carried out, and is of
particular value for some compounds such as pheny-
toin and carbamazepine. For other agents (such as val-
proate), the measurement of serum concentrations is
irrelevant unless a lack of compliance or toxicity is
suspected.
Over the past 20 years AED prescribing patterns have
changed. It has been recognized that the older AEDs
(phenobarbitone, primidone and phenytoin) have an
adverse effect on cognitive function even when serum
concentrations are within the therapeutic range2. In ad-
dition, the recognition that polypharmacy is more likely
than monotherapy to cause cognitive impairment (as
well as increasing the likelihood of side-effects) led to
a push towards monotherapy3. This view is now being
challenged, as research unravels the mode of action
of AEDs, raising the possibility of ‘rational polyphar-
macy’ combining compounds with different or com-
plementary modes of action.
There have been many studies looking at epilepsy in
the learning disabled. In his survey of disabled children
in Camberwell, Corbett (1975) found that a third ofc© 1999 BEA Trading Ltd
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Table 1: Aetiology of learning disability.
Aetiology
Not known 16 (31.4%)
Birth asphyxia 9 (17.6%)
Post-natal infection 4 (7.8%)
Tuberose sclerosis 3 (5.9%)
Head injury 3 (5.9%)
Down’s syndrome 3 (5.9%)
Toxaemia 3 (5.9%)
Congenital rubella 2 (3.9%)
Prematurity 2 (3.9%)
Hydrocephalus 1 (2%)
Rhesus incompatibility 1 (2%)
Normal until epilepsy 1 (2%)
Microcephaly 1 (2%)
Chemotherapy during pregnancy 1 (2%)
Placental insufficiency 1 (2%)
Table 2: Associated medical disorders.
Disorder
Cerebral palsy 15 (29.4%)
Constipation 11 (21.6%)
Gastrointestinal disorders 6 (11.8%)
Hypothyroidism 5 (9.8%)
Skin disorders 5 (9.8%)
Blind 4 (7.8%)
Hearing impairment 3 (5.8%)
Asthma 2 (3.9%)
Other 15 (29.4%)
Table 3: Psychiatric/Developmental disorders.
Diagnosis
Autism 4 (7.8%)
Schizophrenia 3 (5.8%)
OCD 2 (3.9%)
Bipolar affective disorder 1 (2%)
Depression 1 (2%)severely retarded children had suffered seizures at some
time and a fifth had experienced at least one seizure in
the previous year. He and others have also shown that
the prevalence of epilepsy increases with the severity
of learning disability4–6.
Other studies have looked at prescribing patterns of
AEDs in the learning disabled. Some studies have in-
volved audits of hospital populations7–9 or community
samples10. Other studies have looked at populations
of people with epilepsy and a learning disability and
monitored them over a period of time with the aim of
reducing AED prescribing. These studies have shown
that polytherapy can often be reduced without worsen-
ing seizure control11–13.
The previous studies have tended to focus on AED
prescribing and seizure frequency without taking other
relevant factors into account. These include investiga-
tion results, side-effects (including blood abnormali-
ties) and the possible effects of other drugs prescribed.
The present study involved a survey of AED prescrib-
ing in a population of people with a learning disability
and epilepsy. The aims were: (a) to assess the use of the
older vs. the newer AEDs; (b) to assess the prevalence
of side-effects of the AEDs; (c) to look at the possible
effects of other drugs prescribed and other diagnoses;
and (d) to compare the findings to those in a previous
survey of the same population.
Materials and Methods
Monyhull Hospital is a large Learning Disability hos-
pital in South Birmingham. In 1993, and again in 1997,
all inpatients who were being treated for epilepsy with
AEDs were identified. A retrospective case-note analy-
sis was undertaken. Information collected included age,
sex, severity of learning disability, cause of primary
handicap, co-existing medical or psychiatric illnesses,
previous investigations, AEDs prescribed, seizure fre-
quency over the period and the types of seizures
recorded.
The 1993 survey examined prescribing over a 3
month period. The 1997 survey was of a 2 year period
(1/1/95 to 31/12/96). Additional information collected
in the latter survey included the age of the patient at the
onset of the epilepsy, notes made of side-effects from
the AEDs, abnormal blood results, other medication
prescribed and any changes in AED type or dose.
The data were analysed using SPSS version 7.5.
Results
In December 1995 there were 123 patients in Mony-
hull Hospital. Of these, 37 (30.1%) were being treated
for epilepsy. A further 14 patients receiving respite careat the hospital had epilepsy and were included in the
study. Of the 51 patients studied, 33 (64.7%) were male
and 18 (35.3%) were female. Their ages ranged from 20
to 92 years (mean 45.2 years). Eight (16%) patients had
a mild learning disability, 5 (10%) moderate, 32 (63%)
severe and 6 (12%) had a profound learning disabil-
ity. The causes of the patients’ learning disabilities are
summarized in Table 1.
Other diagnoses and treatments
Eleven patients (21.6%) had an additional psychiatric
or developmental disorder and 38 (74.5%) had one or
more additional physical disorders. Tables 2 and 3 sum-
marize the diagnoses.
Forty people (78.4%) were receiving other med-
ications, of which 17 (33.3%) were antipsychotics,
16 (31.3%) were bowel medications and 29 (56.9%)
were other types of drugs. Eleven people (21.6%) were
receiving three or more additional drugs.
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Table 4: AED prescriptions (figures in parentheses refer to
1993 data).
Number of Number as
AED prescriptions % sole agent %
Carbamazepine 33 64.7 (67.5) 11 47.8
Sodium valproate 47 54.9 (47.5) 7 30.4
Phenobarbitone 3 5.8 (12.5) 2 8.7
Phenytoin 6 11.8 (12.5) 1 4.3
Lamotrigine 11 21.6 (5.0) 1 4.3
Gabapentin 3 5.8 (0.0) 0 0.0
Vigabatrin 2 3.9 (2.5) 0 0.0
Primidone 4 7.8 (5.0) 1 4.3
Clobazam 3 5.8 (0.0) 0 0.0Epilepsy
The age at which the diagnosis of epilepsy was con-
firmed was known in 35 patients, and varied from 0.1
to 70 years (mean 11.2 years). Twenty-one (41.2%)
patients were classified as having generalized seizures
(tonic–clonic, tonic, clonic, absence and myoclonic)
with 18 suffering from tonic–clonic seizures only.
Three patients (5.9%) had partial seizures with or
without secondary generalization. Twenty-seven peo-
ple (52.9%) had epilepsy that was unclassified or had
multiple seizure types. Eighteen of the latter had a se-
vere or profound learning disability.
Seven seizures charts were missing from the notes
and could not, therefore, be included in the results. In
addition, 14 patients were admitted for respite only.
For six of the 14, although seizures had been moni-
tored in hospital, no home-kept diaries were available.
Seizures recorded per annum varied from 0 to 134 in
the first year (mean 12.2) and 0 to 169 in the sec-
ond year (mean 17.8). The majority of patients had
well-controlled epilepsy, with 11 (21.6%) suffering no
seizures in the 2 year period and 26 (51%) having an
average of two or fewer seizures per month.
Antipsychotic medication and severity of learning
disability
People receiving antipsychotic medication had an av-
erage of 15.3 seizures over the 2 years, compared to
the average for the group as a whole of 30 seizures
over 2 years. Those patients with a severe or profound
learning disability had an average of 34.8 seizures.
Anticonvulsant drugs
Twenty-three (45.1%) patients were receiving one
AED only, 17 (33.3%) were receiving two, 8 (15.7%)
were receiving three drugs and 3 (5.9%) were receiving
four AEDs. Table 4 shows the AEDs prescribed, and
those used as the sole agent.
Four (7.8%) patients were receiving dosages of AED
which were above the BNF recommended level.
Thirteen (25.5%) patients were receiving one of the
older AEDs (phenobarbitone, phenytoin or primidone).
Their ages ranged from 20 to 92 years with an average
of 59.8 years. Four (30.8%) of these had had no seizures
in the previous 2 years, and one person had only had
one seizure. Two out of these five had undergone re-
ductions in their AED and another patient’s AED had
been successfully stopped.Sixteen (31.4%) patients were receiving one of the
newer AEDs (lamotrigine, gabapentin, vigabatrin). In
six patients, lamotrigine had been commenced because
of uncontrolled seizures. In one patient it was started
as the sole AED and the patient became seizure free.
In the other five patients it was started as an adjunct
to other AEDs. In two of these, the seizures reduced
in frequency. In another two, no change was recorded.
In the sixth patient it was later stopped due to lack of
effect.
Gabapentin was started in four respite patients. In
one, a note was made of a reduced frequency of
seizures. In two cases there were no recorded changes in
seizure frequency. In the fourth patient, the gabapentin
was commenced too late in the study period for any
effect to be recorded. Gabapentin was the fourth AED
in three cases and the third in one case. Both of the
vigabatrin prescriptions had been commenced prior to
the study period.
Side-effects reported in the notes included ataxic
gait in 2 (3.9%), falls in 1(2%) and hirsutism in
1(2%). These four reports were all from patients receiv-
ing sodium valproate. Also reported were prolonged
rashes in 2 (3.9%) people receiving carbamazepine
and gabapentin, lethargy associated with phenytoin and
dizziness with lamotrigine. There was also one report
of confusion, ataxic gait, lethargy and anorexia with
carbamazepine, the patient also having hyponatraemia.
Investigations
Twenty (39%) patients had never had an EEG. One
EEG had been performed for 18 (35%) of the patients,
two EEGs for 7 (14%), three EEGs for 4 (7.8%) and
four or more EEGs for 2 (4%) patients. Out of the 54
EEGs which had been performed, 13 were reported as
normal and 41 (76%) as abnormal.
Forty-five (98%) patients had never had a CT brain
scan. Out of the six reported CTs, 5 (83%) detected
abnormalities.
A total of 26 abnormal blood results were reported
for the 51 patients. Seven (14%) patients had a report
of hyponatraemia (with sodium values ranging from
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low calcium level. In all cases the patient was receiving
carbamazepine. Conversely, 21.2% of patients receiv-
ing carbamazepine had a report of hyponatraemia.
Anaemia was reported in 10 (19%) patients, macro-
cytosis in 2 (4%), neutropenia in 4 (8%) and raised
alkaline phosphatase in 2 (4%).
Twenty-three (45.1%) patients had at least one re-
ported serum AED level taken for one or both of the
12 month periods. Dosage changes were made in 8
(16%) of these as a result of abnormal serum levels.
Comparison with 1993 Survey (1995/96 results
are written in parentheses)
The population resident at Monyhull Hospital in De-
cember 1993 comprised 148 patients. Forty or 27%
(30.1%) of these were receiving AED medication. The
proportions of people with different severities of learn-
ing disability were as follows: mild in 30% (16%),
moderate in 37.5% (10%), severe in 17.5% (63%) and
profound in 5% (12%). Out of all the patients tak-
ing AEDs, 52.5% (21.6%) had an additional psychi-
atric disorder.
Ninety percent (41.2%) of patients were classified as
suffering from generalized seizures, 5% (5.9%) from
partial seizures with or without secondary generaliza-
tion and 5% (52.9%) from multiple seizure types or
were unclassified. Seizure control was very similar for
the two surveys with 25% (21.6%) seizure free in 1993
and 55% (51%) having two or less seizures per month.
Table 4 shows the percentages of patients prescribed
each of the AEDs in 1993. Ninety percent of patients
were receiving one or two AEDs compared to 82.4% in
1995/96. Serum AED levels had been taken in 87.5%
(45.1%) of patients.
There were no EEG reports for 27.5% (39%) of pa-
tients. Full blood counts had been taken in 85% of pa-
tients and biochemistry (U&Es/LFTs) in 57.5%.
Discussion
Our study was conducted on two occasions, comparing
a survey of 1993 vs. 1995/96 results of patients pre-
scribed AEDs in a Learning Disability hospital. At the
time of these surveys, the hospital population studied
was undergoing a process of resettlement. This prob-
ably explains some of the differences. For example,
there were higher numbers of patients with epilepsy
and more with severe learning disability in 1995/6 com-
pared to 1993. The proportions remain similar if the
respite patients included in the second survey are ex-
cluded (74% with a severe or profound learning disabil-
ity overall in 1995/6 and 69.7% in long stay patients
alone).Our findings for the proportion of patients in a Learn-
ing Disability hospital population with epilepsy (27%
and 30.1%) are similar to those reported in other stud-
ies7, 12. Over 90% of the seizures were generalized or
multiple seizures, which is higher than that found in
other studies6. However, it is difficult to be certain of
the accuracy of the classification. There were several
charts with both complex partial and absence seizures
recorded. It may be that staff are confusing the two. In
addition, seizures classed as tonic–clonic could in some
cases have been partial with secondary generalization.
There is also a marked difference between the two sur-
veys in the number of people suffering from multiple
seizure types/unclassified (5% compared to 52.9% in
1993) as well as generalized seizures (41.2% compared
to 90% in 1993). These differences, again, may be due
to inaccurate recording. The results of the survey by
Singh and Towle9 suggest that the 1993 records may be
more accurate. They looked at 100 community charts
of patients with a learning disability and found that pa-
tients with a more severe level of learning disability
tended to have a more mixed pattern of seizures.
Our finding of over a third of patients receiving anti-
psychotic drugs is in keeping with Fishbacher’s result.
His survey in 1987 of prescribing in a Mental Handicap
hospital found that a third of all the patients were taking
an antipsychotic drug8. Surprisingly, despite the known
epileptogenic tendencies of antipsychotic drugs, this
latter group in our study had an average seizure fre-
quency which was lower than for the group as a whole.
This is in keeping with the finding by Brodtkorb et
al. in 1993 who found a negative correlation between
seizure activity and neuroleptic dosage in a group of
institutionalized mentally retarded patients14.
Less than half of the patients were receiving mono-
therapy. In addition, the numbers receiving one or two
AEDs dropped from 90% to 82.4% in the interval be-
tween the two surveys. A similar two-point survey of
a Learning Disability hospital by Amaladoss9 found
that the percentage of patients on one or two AEDs
dropped from 80% to 66% despite implementation
of quality standards after the first survey. Other stud-
ies have shown figures of around 60% of people be-
ing treated with monotherapy7, 8, 10, 12. However, most
of these studies did not indicate the severity of the
epilepsy. In Collacott’s study12, 37% were seizure free
compared to our 21.6%, and 52% suffered less than one
seizure per year compared to our 31.4%. This indicates
that our population had less well-controlled seizures
and this is probably a feature of the change in the hos-
pital population as already described. In addition, at the
time of the study the newer AEDs were licensed solely
as ‘add on’ therapies. Their increased use between the
two surveys would, therefore, possibly distort the pic-
ture. A similar picture emerged in the study by Amal-
adoss9 who found an increase in patients on three or
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tal Retardation 1993; 98, Suppl.: 41–46.more drugs. In these cases one of the newer AEDs had
been added to the regime.
Over a quarter of the patients were on one of the
older AEDs, with patients as young as 20 years receiv-
ing such prescriptions. However, the number of pre-
scriptions for all of the older AEDs except primidone
fell between 1993 and 1995. In contrast, the number of
prescriptions for the newer AEDs increased over this
period. Gabapentin having not been prescribed at all
in 1993 was being used in 95/96 for more intractable
cases and in a quarter of these a reduced frequency
of seizures was reported. One patient (17%) on lamot-
rigine became seizure free and a third had a reduced
frequency. Bhaumik et al. in 1997 looked at the pre-
scribing of vigabatrin, lamotrigine and gabapentin in
consultant caseloads of patients with a learning dis-
ability14. They found that no patients became seizure
free on lamotrigine but that over a third underwent a
greater than 50% reduction in seizure frequency. Over
half experienced the same reduction with gabapentin.
One patient (17%) on lamotrigine in our study had to
discontinue due to lack of effect compared to over a
quarter in Bhaumik et al.’s group.
Regarding investigations, it is often a challeng-
ing task to perform EEGs and CT scans on people
with a learning disability. However, our results show
that a high proportion of abnormalities are picked
up (75% of EEGs and 83% of CT scans). Whether
this helped in the management of the epilepsy is not
clear.
Blood tests, however, being a more amenable inves-
tigation, could possibly be performed too frequently
and for insufficient reason. We found a high proportion
of abnormal blood results. Nearly a fifth of the patients
were anaemic. Over a quarter had other blood abnor-
malities which indicated AED side-effects. Particularly
notable of these is the high proportion of people tak-
ing carbamazepine who had hyponatraemia (21.2%).
There are no similar studies to compare with in this in-
stance. Critchlow15 in 1998 looked at a population of
psychiatric patients and found five out of 19 with hy-
ponatraemia were taking carbamazepine. Amaladoss9
found hyponatraemia in six patients (8%) but no men-
tion was made of which AED they were receiving.
With regard to AED serum levels, our results showed
that over a third of patients who had their serum levels
checked had an AED dosage change as a consequence
of the level. A study by Jackson et al. in 1994 looking
at a population with epilepsy in a Learning Disability
hospital, found that serum levels for AEDs other than
phenobarbitone appeared to fluctuate considerably for
unexplained reasons17. They concluded that one serum
level is insufficient evidence on which to base an alter-
ation in AED dose.
This study highlights the information that can be
gathered by a survey of a learning disabled popula-tion, especially where changes over time can be eval-
uated. Reductions in the number and dose of AEDs
may be facilitated by such an audit of seizure fre-
quency, seizure type and AED side-effects. With the
move into the community, a proportion of this popula-
tion may be cared for by staff who lack experience in
seizure identification. Our findings suggest that even
among trained staff, identification is difficult. Educa-
tional input directed at identifying seizures and AED
side-effects would be one strategy to improve epilepsy
management.
Limitations of our study included the fact that the
majority were institutional residents, and a large pro-
portion had a severe learning disability. They were
not, therefore, a representative sample and the num-
bers audited were relatively small. The study was
retrospective, and was therefore limited by the qual-
ity of the information recorded. Unfortunately, ow-
ing to the small numbers and the short study pe-
riod no firm conclusions can be drawn regarding
the use of the newer AEDs in the learning dis-
abled. This is clearly an area in which more work
needs to be done. In addition, for this particular
population, a further survey following their move
into the community would be useful and is being
planned.
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